While retatrutide Phase 2 data showed improvements in cardiovascular risk markers, individual responses vary, and new cardiac symptoms during any peptide protocol should be evaluated immediately
They provide strong proof that a compound has a direct biological effect on the target tissue, but they cannot tell us how that compound will behave when applied to human skin (where absorption, distribution, and metabolism add complexity)
The mention of any brand, product, or service does not constitute an endorsement or guarantee of effectiveness or safety
Published investigations describe temporary injection site irritation, redness, mild swelling, local discomfort, and headache among the most commonly observed findings
Beyond that, studies suggest it has powerful anti-inflammatory effects and may directly accelerate the regeneration of tendon, muscle, ligament, and even bone tissue